Provided by Tiger Fintech (Singapore) Pte. Ltd.

Magenta Therapeutics Inc.

11.19
+0.0000
Volume:- -
Turnover:268.84K
Market Cap:42.24M
PE:-0.61
High:11.19
Open:11.19
Low:11.19
Close:11.19
Loading ...
Sep 22, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 22, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 21, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Sep 16, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 31, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Correspondence

Form CORRESP - Correspondence
Jul 17, 2023

Correspondence

Form CORRESP - Correspondence
Jun 23, 2023

Correspondence

Form CORRESP - Correspondence
May 20, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 19, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Business Combinations

425 - Prospectuses and communications, business combinations
May 01, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]